Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinbang Mesenchymal Stem Cell Injection in Knee Osteoarthritis
CTR20233065Phase 2Completed
- Sponsor
- Shandong Xingrui Biotechnology
- Start
- Oct 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Xinbang mesenchymal stem cell injection in knee osteoarthritis (OA), sponsored by Shandong Xingrui Biotechnology. Started Oct 2023; status: completed.
02
Drugs
Xinbang mesenchymal stem cell injection
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20233065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233065.